|
1
|
Han HJ, Russo J, Kohwi Y and
Kohwi-Shigematsu T: SATB1 reprogrammes gene expression to promote
breast tumor growth and metastasis. Nature. 452:187–193. 2008.
View Article : Google Scholar
|
|
2
|
Parker B and Sukumar S: Distant metastasis
in breast cancer: molecular mechanisms and therapeutic targets.
Cancer Biol Ther. 2:14–21. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hao ZH, Li X, Qiao T, Du R, Hong L and Fan
D: CIAPIN1 congers multidrug resistance by upregulating the
expression of MDR-1 and MRP-1 in gastric cancer cells. Cancer Biol
Ther. 5:261–266. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ozben T: Mechanisms and strategies to
overcome multiple drug resistance in cancer. FEBS Lett.
580:2903–2909. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pienta KJ and Smith DC: Advances in
prostate cancer chemotherapy: a new era begins. CA Cancer J Clin.
55:300–318. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Spector DL: The dynamics of chromosome
organization and gene regulation. Annu Rev Biochem. 72:573–608.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cai S, Han HJ and Kohwi-Shigematsu T:
Tissue-specific nuclear architecture and gene expression regulated
by SATB1. Nature Genet. 34:42–51. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yasui D, Miyano M, Cai S, Varga-Weisz P
and Kohwi-Shigematsu T: SATB1 targets chromatin remodelling to
regulate genes over long distances. Nature. 419:641–645. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dickinson LA, Joh T, Kohwi Y and
Kohwi-Shigematsu T: A tissue-specific MAR/SAR DNA-binding protein
with unusual binding site recognition. Cell. 70:631–645. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Agrelo R, Souabni A, Novatchkova M,
Haslinger C, Leeb M, Komnenovic V, Kishimoto H, Gresh L,
Kohwi-Shigematsu T, Kenner L and Wutz A: SATB1 defines the
developmental context for gene silencing by Xist in lymphoma and
embryonic cells. Dev Cell. 16:507–516. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakayama Y, Mian IS, Kohwi-Shigematsu T
and Ogawa T: A nuclear targeting determinant for SATB1, a genome
organizer in the T cell lineage. Cell Cycle. 4:1099–1106. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alvarez JD, Yasui DH, Niida H, Joh T, Loh
DY and Kohwi-Shigematsu T: The MAR-binding protein SATB1
orchestrates temporal and spatial expression of multiple genes
during T-cell development. Genes Dev. 14:521–535. 2000.PubMed/NCBI
|
|
13
|
Zheng J: Is SATB1 a master regulator in
breast cancer growth and metastasis? Womens Health (Lond Engl).
4:329–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li QQ, Chen ZQ, Xu JD, Cao XX, Chen Q, Liu
XP and Xu ZD: Overexpression and involvement of special AT-rich
sequence binding protein 1 in multidrug resistance in human breast
carcinoma cells. Cancer Sci. 101:80–86. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu X, Cheng C, Zhu S, Yang Y, Zheng L,
Wang G, Shu X, Wu K, Liu K and Tong Q: SATB1 is an independent
prognostic marker for gastric cancer in a Chinese population. Oncol
Rep. 24:981–987. 2010.PubMed/NCBI
|
|
16
|
Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD
and Wang LH: Twist transcriptionally up-regulates AKT2 in breast
cancer cells leading to increased migration, invasion, and
resistance to paclitaxel. Cancer Res. 67:1979–1987. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li QQ, Wang WJ, Xu JD, Cao XX, Chen Q,
Yang JM and Xu ZD: Involvement of CD147 in regulation of multidrug
resistance to P-gp substrate drugs and in vitro invasion in breast
cancer cells. Cancer Sci. 98:1064–1069. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi Y, Zhai H, Wang X, Han Z, Liu C, Lan
M, Du J, Guo C, Zhang Y, Wu K and Fan D: Ribosomal proteins S13 and
L23 promote multidrug resistance in gastric cancer cells by
suppressing drug-induced apoptosis. Exp Cell Res. 296:337–346.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maxwell SA and Davis GE: Biological and
molecular characterization of an ECV-304-derived cell line
resistant to p53-mediated apoptosis. Apoptosis. 5:277–290. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wen J, Huang S, Rogers H, Dickinson LA,
Kohwi-Shigematsu T and Noguchi CT: SATB1 family protein expressed
during early erythroid differentiation modifies globin gene
expression. Blood. 105:3330–3339. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Y, You H, Liu F, An H, Shi Y, Yu Q
and Fan D: Differentially expressed gene profiles between multidrug
resistant gastric adenocarcinoma cells and their parental cells.
Cancer Lett. 185:211–218. 2002. View Article : Google Scholar
|
|
22
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Su M, Zhou LL, Tu P, Zhang X,
Jiang X and Zhou Y: Deficiency of SATB1 expression in Sezary cells
causes apoptosis resistance by regulating FasL/CD95L transcription.
Blood. 117:3826–3835. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gorlick R and Bertino JR: Drug resistance
in colon cancer. Semin Oncol. 26:606–611. 1999.
|
|
25
|
Naito S, Yokomizo A and Koga H: Mechanisms
of drug resistance in chemotherapy for urogenital carcinoma. Int J
Urol. 6:427–439. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong X and Mumper RJ: Nanomedicinal
strategies to treat multidrug-resistant tumors current progress.
Nanomedicine (Lond). 5:597–615. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Colone M, Calcabrini A, Toccacieli L,
Bozzuto G, Stringaro A, Gentile M, Cianfriglia M, Ciervo A,
Caraglia M, Budillon A, et al: The multidrug transporter
P-glycoprotein: a mediator of melanoma invasion? J Invest Dermatol.
128:951–971. 2008. View Article : Google Scholar
|
